Prelude Therapeutics Incorporated

What is Prelude Therapeutics Incorporated (PRLD) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, Prelude Therapeutics Incorporated (PRLD) stock is trading at $1.92. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PRLD stock quotes for informed trading decisions.

What is Prelude Therapeutics Incorporated's market capitalization?

Prelude Therapeutics Incorporated (PRLD) has a market capitalization of approximately $105.9M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Prelude Therapeutics Incorporated's size relative to other companies in the USD market. The market cap figure updates automatically as the PRLD stock price changes.

What is the 52-week range for Prelude Therapeutics Incorporated stock?

Prelude Therapeutics Incorporated (PRLD) stock has traded in a 52-week range of $0.61 — $4.22. The 52-week range shows the highest and lowest prices at which PRLD traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Prelude Therapeutics Incorporated stock price to this range provides context for recent price action.

How much trading volume does Prelude Therapeutics Incorporated stock have?

Prelude Therapeutics Incorporated (PRLD) stock recently traded approximately 1.1M shares. Trading volume indicates market liquidity and investor interest in PRLD. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Prelude Therapeutics Incorporated stock.

Does Prelude Therapeutics Incorporated pay dividends to shareholders?

Yes, Prelude Therapeutics Incorporated (PRLD) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Prelude Therapeutics Incorporated stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Prelude Therapeutics Incorporated's intraday price range?

Today, Prelude Therapeutics Incorporated (PRLD) stock has traded in a range of $1.71 — $1.98. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PRLD's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Prelude Therapeutics Incorporated stock data?

AlphaPilot sources real-time PRLD stock quotes, fundamental financial data, and historical price charts for Prelude Therapeutics Incorporated from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Prelude Therapeutics Incorporated stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PRLD stock performance.